16 "Prostate" clinical trials found.
-
TRITON3: A Multicenter Randomized Open-label Phase 3 Study of Rucaparib versus Physician s Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency
If you have been diagnosed with prostate cancer, that is found to be metastatic castration-resistant, which is a disease state characterized by resistance to ...
Phase
Interventional
Match Level: Exact
-
TRITON2: A Multicenter Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency
If you have been diagnosed with prostate cancer, that is found to be metastatic castration-resistant, which is a disease state characterized by resistance to ...
Phase
Interventional
Match Level: Exact
-
Prospective Databased of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer
The purpose of this study is to better understand how well Cryo Ablation treats prostate cancer and the long-term effects of this treatment of sexual ...
Phase N/A Match Level: Exact
-
PET/MRI (AXUMIN) STUDY OF MEN WITH HIGHLY SUSPICIOUS MRI LESIONS THAT SHOWED NO CLINICALLY SIGNIFICANT PROSTATE CANCER FOLLOWING MRI FUSION TARGETED BIOPSY
The objective of this study is to find out if positron emission tomography (PET) imaging with 18-F fluciclovine (Axumin) identifies clinically significant prostate cancer in ...
Phase N/A
Observational
Match Level: Exact
-
A Phase 1 Open-Label Study of the Safety Tolerability and Efficacy of KPT-9274 A Dual Inhibitor of PAK4 and NAMPT in Patients with Advanced Solid Malignancies or Non-Hodgkin's Lymphoma (PANAMA)
if you are newly diagnosed with non-Hodgkin's lymphoma or advanced solid malignancies, you may qualify to participate in a clinical trial. The main goal ...
Phase
Interventional
Match Level: Exact
-
Data Visualization of Kidney and Prostate Tumors using Routine Pre-Operative Imaging 3D Printed and 3D Virtual Reality Models
If you are scheduled to have kidney or prostate cancer surgery, you may qualify for this study. The main goal of this study is to ...
Phase N/A Match Level: Exact
-
An open-label dose-finding and proof of concept study for Probody Therapeutics (Probody Tx) in subjects with metastatic or locally advanced unrespectable solid tumors and/or lymphomas
If you have been diagnosed with a metastatic or advanced unresectable solid tumor or lymphoma, you may qualify for this study evaluating the investigational drug ...
Phase
Interventional
Match Level: Exact
-
A Phase I Open Label Study of GSK3359609 Administered alone in Combination with Anticancer Agents in Subjects with Selected Advanced Solid Tumors
If you have been diagnosed with selected advanced or recurrent solid tumors including bladder cancer, cervical cancer, colorectal cancer, esophageal cancer with squamous cell ...
Phase
Interventional
Match Level: Exact
-
A PHASE 1B/2 STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF AVELUMAB IN COMBINATION WITH THE POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) INHIBITOR TALAZOPARIB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
If you have been diagnosed with either prostate, lung cancer, breast cancer, ovarian cancer, or urothelial cancer you may qualify to participate in a study ...
Phase
Interventional
Match Level: Exact
-
ProSTAR: A Phase 1b/2 Study of CPI-1205 a Small Molecule Inhibitor of EZH2 Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer
This Phase 1b/2 trial is testing a drug, CPI-1205, that targets the EPIGENETICS of metastatic Castration Resistant Prostate Cancer. The main goal of the study ...
Phase
Interventional
Match Level: Exact
